You are here:Home-Chemical Inhibitors & Agonists-Metabolic Enzyme/Protease-Protein Phosphatase/PTP-PRL inhibitor Cmpd-43
PRL inhibitor Cmpd-43

Chemical Structure : PRL inhibitor Cmpd-43

CAS No.: 331431-75-5

PRL inhibitor Cmpd-43 (Cmpd-43)

Catalog No.: PC-21504Not For Human Use, Lab Use Only.

PRL inhibitor Cmpd-43 is a specific small molecule inhibitor and detrimerizer of phosphatase of regenerating liver (PRL), significantly decreases PRL1 trimer formation inside the cell.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

PRL inhibitor Cmpd-43 is a specific small molecule inhibitor and detrimerizer of phosphatase of regenerating liver (PRL), significantly decreases PRL1 trimer formation inside the cell.
PRL inhibitor Cmpd-43 (20 uM) does not inhibit the phosphatase activity of PRL1 as well as a large panel of PTPs including receptor-like PTPs, PTPμ, PTPε, LAR, PTPσ and PTPγ, cytosolic PTPs, PTP1B, Lyp, SHP1, PTPH1, HePTP, STEP, and PEZ, the dual specificity phosphatase VHR, VHZ, MKP5, CDC14A, and the low molecular weight PTP.
Cmpd-43 (0.1-50 uM) inhibits PRL1 induced cell proliferation and migration in a dose dependent manner in PRL1 expressing HEK293 cells.
Cmpd-43 also markedly delays the wound closure induced by PRL1 overexpression.
Cmpd-43 exerts anti-proliferative activity through blocking PRL1 trimerization.
Cmpd-43 inhibits PRL1-induced ERK1/2 and Akt activation in MeWo cells by blocking PRL1 trimerization.
Cmpd-43 (30 mg/kg) suppresses melanoma xenograft growth in vivo.
Cmpd-43 phenocopies the effect of genetic deletion of Prl2 and reduces Tp53 deficiency-induced tumor growth.

Physicochemical Properties

M.Wt 413.48
Formula C25H23N3O3
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

(Z)-4-((2-(3-(5,6-dimethylisoindolin-2-yl)benzoyl)hydrazineylidene)methyl)benzoic acid

References

1. Yunpeng Bai, et al. Cancer Res. 2016 Aug 15;76(16):4805-15.

2. Nguele Meke F, et al. Cancer Res Commun. 2023 Dec 2. doi: 10.1158/2767-9764.CRC-23-0308.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: